对患有炎症性关节炎的个人进行疲劳和活动管理教育工作 (FAME-W) 干预措施的有效性进行测试:随机对照试验研究方案
Shalaleh Karkon1, Kathleen E Bennett2, Finbarr O'Shea3
1Discipline of Occupational Therapy, Trinity Centre for Health Sciences, St. James' Hospital, Dublin, Ireland.
Musculoskeletal care
|November 8, 2023
概括
劳动疲劳和活动管理教育 (FAME-W) 计划帮助炎症性关节炎患者管理疲劳,以提高工作绩效. 这项研究在随机对照试验中测试了其有效性和可接受性.
科学领域:
- 类风湿病学 类风湿病学
- 职业健康 职业健康 职业健康
- 临床试验方法论 临床试验方法论
背景情况:
- 疲劳严重影响炎症性关节炎 (IA) 患者,影响他们维持工作活动的能力.
- 劳动疲劳和活动管理教育 (FAME-W) 计划是为了解决IA患者的与工作有关的疲劳而开发的.
- 本研究方案概述了一项随机对照试验,以评估FAME-W计划的有效性和可接受性.
研究的目的:
- 测试FAME-W计划在改善炎症性关节炎患者工作表现方面的有效性.
- 评估参与者和促进者对FAME-W计划的接受度.
- 探索FAME-W对疲劳,情绪,与健康有关的生活质量和疼痛的影响.
主要方法:
- 一个多站点随机对照试验与混合方法的过程评估.
- 将招募有薪工作的患有炎症性关节炎的参与者 (18-65岁).
- 主要结果:工作角色功能 (WRF) 问卷;次要结果:疲劳,情绪,HRQOL,疼痛. 在干预前,干预后和3个月后期收集的数据.
- 过程评估包括重点小组,个人访谈和促进者日志,以评估忠实性和可接受性.
主要成果:
- 预期的结果表明,FAME-W通过为参与者提供疲劳和相关症状的自我管理策略来提高工作绩效.
- 预计这项干预措施将提高参与者管理其工作活动需求的能力.
结论:
- 假设FAME-W计划是炎症性关节炎患者的有效和可接受的干预措施.
- 预计成功实施将通过加强症状管理来提高工作绩效.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
147
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
147
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170